Deliver the right dose, in the right form, with the right performance.
At Syner-G, we push the boundaries of small molecule drug development. Our mission is to drive pharmaceutical innovation with a global impact on patient care. Our team of expert consultants are more than just seasoned professionals—they are pioneers in their field, ready to guide your programs from discovery through to successful market launch with inventive strategies and cutting-edge solutions.
With decades of experience, our integrated approach helps propel your programs forward and prepares your assets for clinical and commercial success. From early development, where balancing form and function with speed and efficiency is key, to late-stage, robust dosage forms, we tailor solutions that align with your specific phase and strategy.
Challenges we can help solve:
Limited technical talent
Our integrated teams guide your earliest decisions with cross-functional expertise that aligns science, quality, and long-term objectives.
Unclear development plan
We design and execute forward-looking, risk-managed programs that reduce downstream issues—and speed your asset through development and approval.
Complex, time-sensitive submission demands
Our experienced scientists craft clear, compliant regulatory documents that meet global standards and support every step of the submission process. From authoring and editing to formatting, QC, and coordination, we help clients meet tight timelines for INDs, NDAs, MAAs, and agency briefings—without compromising quality.
Regulatory uncertainty and evolving expectations
We help you interpret and apply global regulatory requirements through a fit-for-purpose, risk-based approach grounded in scientific and operational insight. Whether you’re pursuing an IND, NDA, BLA, or global filings, our experts guide you through every step with clarity and precision.
Pressure to scale quickly
We accelerate execution across engineering, validation, and operations—helping you avoid multimillion dollar delays and hit your launch window.
Inconsistent documentation or quality gaps
Our cross-functional experts identify and remediate documentation gaps, harmonize submission standards, and support audit readiness—ensuring your programs meet evolving regulatory expectations even post-launch.
Missed milestones
Our integrated model helps clients avoid regulatory setbacks, quality gaps, and disconnected development plans that could delay key milestones—or jeopardize investor confidence.
Assets Supported
INDs Filed
Client Repeat Rate
Fast-track your path from discovery to market.
Trusted by thousands of innovators.
Our client-first approach ensures that your science stays on track, your documentation holds up to agency scrutiny, and your team gets the support it needs to scale.
End-to-end guidance across the entire pharmaceutical development lifecycle.
We combine unmatched, domain expertise with innovative strategies to turn your groundbreaking science into life-changing therapies. Our holistic support model ensures your programs are compliant, efficient, and primed for global success.
Our Solutions
Science + Strategy + Delivery
Scientific, Regulatory & Quality
Learn More
Strategy & Transformation Consulting
Learn More
Technical Operations & Delivery Infrastructure
Learn More
Related Resources
All Resources
Let's move from science to success.
Let’s Talk